Sphingosine kinase inhibitors
US7220764B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2003 |
| Grant date | May 22, 2007 |
| Priority date | — |
| Expiry date | Jun 17, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/41
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compositions and methods for inhibiting sphingosine kinase and for treating hyperproliferative disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.